[HTML][HTML] Characteristics of patients experiencing extrapyramidal symptoms or other movement disorders related to dopamine receptor blocking agent therapy
S Musco, L Ruekert, J Myers, D Anderson… - Journal of clinical …, 2019 - journals.lww.com
Dopamine receptor blocking agents (DRBAs), also known as antipsychotics, are
medications widely used to treat a growing number of mental health diagnoses. However …
medications widely used to treat a growing number of mental health diagnoses. However …
Healthcare resource utilization and costs of using Cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder
PS Masand, AH Clayton, M Parikh… - Journal of Medical …, 2025 - Taylor & Francis
Aim Inadequate response to antidepressant therapy (ADT) is common in major depressive
disorder (MDD); atypical antipsychotic (AA) adjunctive therapy may be effective for these …
disorder (MDD); atypical antipsychotic (AA) adjunctive therapy may be effective for these …
Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major …
R Jain, F Laliberté, G Germain, M Mahendran… - Journal of Managed …, 2023 - jmcp.org
BACKGROUND: Major depressive disorder (MDD) is a highly prevalent mental health
condition associated with substantial economic burden. Inadequate response to first-line …
condition associated with substantial economic burden. Inadequate response to first-line …
Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view
SK Kar, V Menon - CNS spectrums, 2022 - cambridge.org
Early augmentation is a relatively newer concept in the management of psychiatric
disorders. In managing psychiatric disorders, augmentation strategies are commonly used …
disorders. In managing psychiatric disorders, augmentation strategies are commonly used …
Real-world economic outcomes of brexpiprazole and extended-release quetiapine adjunctive use in major depressive disorder
A Seetasith, M Greene, A Hartry… - ClinicoEconomics and …, 2019 - Taylor & Francis
Purpose Major depressive disorder (MDD) is a chronic mental disorder with a substantial
clinical and economic burden. Despite the efficacy of adjunctive atypical antipsychotics …
clinical and economic burden. Despite the efficacy of adjunctive atypical antipsychotics …
Relevance of Early Augmentation with Electroconvulsive Therapy in Misidentification Syndrome: a Case Report
K Chawla, VK Gupta, A Saroj, A Shankar… - SN Comprehensive …, 2021 - Springer
In schizophrenia, electroconvulsive therapy is most often given to improve the antipsychotic
drug effect. Here, we address the potential function of electroconvulsive therapy's early …
drug effect. Here, we address the potential function of electroconvulsive therapy's early …
[引用][C] Early augmentation in early intervention for mental illness: A potential turbo-boost?
SK Kar, V Menon, SMY Arafat - Asian Journal of Psychiatry, 2021 - europepmc.org
Early augmentation in early intervention for mental illness: A potential turbo-boost? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …